AzTrials
AzTrials

Exercise-induced Muscle SorenessNCT07766720

Effects of Eggshell Membrane and Curcumin Extract Supplementation, Separately or Combined, on Recovery From Intense Exercise

A study testing NEM® brand eggshell membrane powder, curQ+® brand highly absorbable curcumin and NEM® plus curQ+® combination in people with Exercise-induced Muscle Soreness and Exercise-induced Joint Pain, run by ESM Technologies, LLC at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Eggshell membrane and Curcumin supplementation prior to intense exercise may reduce inflammation, muscle and joint pain, and promote recovery. This proof-of-concept study will examine how ingestion of specially formulated versions of these nutrients affects recovery from intense exercise. Read more about this study

Who is it for?
Ages 18 to 40 years, men onlyHealthy volunteers can take part
What is being tested?
NEM® brand eggshell membrane powder, curQ+® brand highly absorbable curcumin and NEM® plus curQ+® combination
Type of treatment
Pill or oral medicine
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
60 participants
Where
1 siteUnited States
Study dates
1 Feb 2026to 31 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Age 18 to 40 at the time of consent.
  • Healthy and recreationally active.
  • Ability to comply with study procedures.
  • Agree to refrain from alcohol intake and use of non-steroidal anti-inflammatory (NSAIDS), aspirin, and other over-the-counter pain medications for 48 hours prior to and after completion of each testing session.

Who cannot join

  • No recent history of exercise training
  • An orthopedic limitation that would prevent the ability to perform the exercise intervention.
  • Participants who currently smoke cigarettes.
  • Known allergies to eggs, sulfur, or curcumin.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Richard B. Kreider, Ph.D. contact

(979) 458-1498

rbkreider@tamu.edu

Christopher Rasmussen, M.S. contact

(979) 458-1498

crasmussen@tamu.edu

United States1 site, 1 recruiting
  • Exercise & Sport Nutrition Lab - Texas A&M University

    College Station, Texas, 77843

    Richard B. Kreider, Ph.D., (979) 458-1498, rbkreider@tamu.edu

    Christopher Rasmussen, M.S., (979) 458-1498, crasmussen@tamu.edu

    Recruiting

Other trials in United States

About this study

Official title: Effects of NEM® Brand Eggshell Membrane and curQ+® Brand Highly Absorbable Curcumin Supplementation, Alone or in Combination, on Recovery From Intense Exercise in Recreationally Active Men.

Eggshell membrane and Curcumin supplementation prior to intense exercise may reduce inflammation, muscle and joint pain, and promote recovery. This proof-of-concept study will examine how ingestion of specially formulated versions of these nutrients affects recovery from intense exercise.

Read the detailed description

Eggshell membrane (EM) is derived from the inner fibrous layer of eggs that contain a number of proteins and Types I, V, and X collagen and sulfur containing amino acids (i.e., e.g., methionine, cysteine), glycosaminoglycans (e.g., hyaluronic acid, dermatan sulfate, chondroitin sulfate) that are found in synovium, cartilage, ligaments, and tendons of human joint tissue. Initial studies have shown that EM supplementation reduces inflammation and perception of pain while improving markers of joint health in individuals with osteoarthritis. Curcumin (Curcuma longa) is a member of the ginger family (Zingiberaceae) that contains polyphenols that have anti-inflammatory properties. Studies show that curcumin (Curc) can reduce inflammation related to osteoarthritis, exercise, concussion and traumatic brain injury. Theoretically, EM and Curc supplementation prior to intense exercise may reduce inflammation, perceptions of muscle and joint pain, and promote recovery. This proof-of-concept study will examine how ingestion of specially formulated versions of these nutrients (NEM® brand eggshell membrane and curQ+® brand highly absorbable curcumin) separately and in combination affects recovery from intense exercise in recreationally active men.

Being tested
NEM® brand eggshell membrane powder, curQ+® brand highly absorbable curcumin, EM Placebo, Curc Placebo, NEM® plus curQ+® combination
Keywords
intense exercise, NEM, curQ+, eggshell membrane, curcumin

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • NEM® brand eggshell membrane powderDietary supplement

    500 mg/day of NEM® brand eggshell membrane powder in a single #0 capsule.

  • curQ+® brand highly absorbable curcuminDietary supplement

    2,860 mg/day of curQ+® brand highly absorbable curcumin in a single 10 Oval softgel.

  • EM PlaceboDietary supplement

    500 mg/day of psyllium husk fiber powder in a single #0 capsule.

  • Curc PlaceboDietary supplement

    2,860 mg/day of coconut oil/polysorbate blend in a single 10 Oval softgel.

  • NEM® plus curQ+® combinationDietary supplement

    500 mg/day of NEM® brand eggshell membrane powder in a single #0 capsule PLUS 2,860 mg/day of curQ+® brand highly absorbable curcumin in a single 10 Oval softgel.

Study groups in NCT07766720
Study groupRoleWhat they receive
Active, EMExperimental500 mg/day of NEM® brand eggshell membrane powder in a single #0 capsule.
Receives: Dietary Supplement: NEM® brand eggshell membrane powder; Dietary Supplement: Curc Placebo
Active, curcExperimental2,860 mg/day of curQ+® brand highly absorbable curcumin in a single 10 Oval softgel.
Receives: Dietary Supplement: curQ+® brand highly absorbable curcumin; Dietary Supplement: EM Placebo
PlaceboPlacebo comparator500 mg/day of psyllium husk fiber powder in a single #0 capsule PLUS 2,860 mg/day of coconut oil/polysorbate blend in a single 10 Oval softgel.
Receives: Dietary Supplement: EM Placebo; Dietary Supplement: Curc Placebo
Active, EM+CurcExperimental500 mg/day of NEM® brand eggshell membrane powder in a single #0 capsule PLUS 2,860 mg/day of curQ+® brand highly absorbable curcumin in a single 10 Oval softgel.
Receives: Dietary Supplement: NEM® plus curQ+® combination

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. VAS Muscle Soreness Rating

    Changes in Visual Analog Scale (VAS) ratings of muscle soreness (rated from zero to 100 mm) from baseline following intense exercise. The higher the rating, the more muscle soreness so negative changes in VAS would equate to improvement.

    Measured: 2 weeks

Secondary outcomes (4)
  1. Urinary CTX-II

    Changes in urinary CTX-II biomarker from baseline following intense exercise.

    Measured: 2 weeks

  2. Muscle Damage

    Changes in markers of muscle enzyme efflux/damage (CK, LDH) from baseline following intense exercise.

    Measured: 2 weeks

  3. Exercise Performance

    Changes in exercise performance (strength, muscular endurance, peak aerobic capacity) from baseline following intense exercise.

    Measured: 2 weeks

  4. Inflammation Biomarkers

    Changes in markers of inflammation (TNFα, interleukin (IL) cytokines (IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10) from baseline following intense exercise.

    Measured: 2 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Aug 2026
  2. Study start1 Feb 2026
  3. Primary completion15 Oct 2026 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Single-Dummy, Placebo-controlled, Parallel-Group
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07766720
Sponsor's protocol ID
STUDY2025-0899
Status last verified
Aug 2026
First submitted
30 Jul 2026
Last updated
14 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing NEM® brand eggshell membrane powder, curQ+® brand highly absorbable curcumin and NEM® plus curQ+® combination in people with Exercise-induced Muscle Soreness and Exercise-induced Joint Pain, run by ESM Technologies, LLC at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 14 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Richard B. Kreider, Ph.D. ((979) 458-1498, rbkreider@tamu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

VAS Muscle Soreness Rating (time frame: 2 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Aug 2026; AzTrials last refreshed its copy on 31 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in